Evidence Explorer / MS-N047
EXERCISE & STEM-CELL TRANSPLANT
Exercise during allogeneic stem-cell transplantation
Evidence label: Small randomized supportive signal · Clinical goal: preserve endurance, strength and quality of life during allogeneic transplantation
Evidence at a glance
- Population: 47 adults undergoing allogeneic hematopoietic stem-cell transplantation.
- Intervention: endurance and daily-living activity twice daily during the inpatient transplant phase.
- Result: endurance, strength, fatigue and emotional-state measures favored exercise over standard once-daily physiotherapy.
What was studied
The randomized trial began exercise alongside conditioning chemotherapy and total-body irradiation. The comparison group received the center’s standard physiotherapy once daily.
What the evidence shows
Differences or favorable trends were reported for endurance (P=.002), strength (P=.022), fatigue (P=.046) and emotional state (P=.028), without additional reported individual risk. The study did not establish effects on graft complications, relapse or survival.
This is supportive-care or rehabilitation evidence. It does not show that the intervention treats cancer, prevents recurrence or prolongs survival unless a record explicitly identifies a validated cancer-control endpoint.
Limits and uncertainty
The trial was small and single-setting, used an active control and reported P values without the absolute effect estimates needed to judge clinical importance. Reviews find heterogeneous programs and outcomes. A separate survival analysis was not designed or stratified to prove survival benefit.
Safety and practical context
Transplant exercise must change with fever, infection, anemia, thrombocytopenia, graft-versus-host disease, lines, falls and isolation requirements. The transplant and rehabilitation teams should set daily limits.
Questions for the care team
- What blood-count or infection thresholds change today’s plan?
- Which exercises are safe with my central line and fall risk?
- Are we measuring endurance, fatigue and function rather than assuming a survival effect?
Sources
- Randomized inpatient trial (PMID 21545527)
- Exploratory survival follow-up (PMID 26061092)
- Cochrane review of aerobic exercise in hematologic malignancy
Literature searched: October 16, 2026 · Record appraised: October 16, 2026
Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.